COX-2 Expression and Opposite Growth Effect of N-3 and-6 PUFAs in Pancreatic Cancer Cell Lines

被引：0
|
作者：
Satake, M. [1 ,2 ]
Kuroda, N. [1 ]
Uyama, N. [1 ]
Hirano, T. [1 ]
Okada, T. [1 ]
Takahashi, M. [1 ]
Eibl, G. [2 ]
Go, V. L. W. [2 ]
Fujimoto, J. [1 ]
机构：
[1] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
PANCREAS | 2009年 / 38卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1043 / 1043
页数：1
相关论文
共 50 条
  • [21] Expression of COX-2 and IDO by Uteroglobin Transduction in NSCLC Cell Lines
    Park, Gun Min
    Lee, Sang-Min
    Yim, Jae-Joon
    Yang, Seok-Chul
    Yoo, Chul Gyu
    Lee, Choon-Taek
    Han, Sung Koo
    Shim, Young-Soo
    Kim, Young Whan
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 274 - 279
  • [22] MiR-143 Decreases COX-2 mRNA Stability and Expression in Pancreatic Cancer Cell
    Pham, Hung
    Donald, Graham
    Hertzer, Kathleen M.
    Jung, Xiaoman Z.
    Rodriguez, Citlali Ekaterina
    Reber, Howard A.
    Hines, Oscar J.
    Eibl, Guido
    GASTROENTEROLOGY, 2013, 144 (05) : S674 - S674
  • [23] Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer
    Matsubayashi, Hiroyuki
    Infante, Jeffrey R.
    Winter, Jordan
    Klein, Alison P.
    Schulick, Richard
    Hruban, Ralph
    Visvanathan, Kala
    Goggins, Michael
    CANCER BIOLOGY & THERAPY, 2007, 6 (10) : 1569 - 1575
  • [24] Effect of apricoxib, a novel COX-2 inhibitor, on the efficacy of standard therapy in human pancreatic cancer cell lines in vitro and in vivo
    Kirane, A. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Cyclooxygenase-2 (COX-2) inhibitor stimulates pancreatic cancer growth
    Eibl, G
    Reber, HA
    Wente, MN
    Hines, OJ
    GASTROENTEROLOGY, 2002, 122 (04) : A489 - A490
  • [26] Selenomethionine inhibits growth and modulates cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines.
    Baines, AT
    Taylor, MT
    Renaud, CE
    Gerner, EW
    Nelson, MA
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3812S - 3812S
  • [27] Effect of n-3 and n-6 eicosanoids on intestinal Caco-2 cell growth
    Cabral, M.
    Martin-Venegas, R.
    Moreno, J. J.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (OCE3) : E309 - E309
  • [28] n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARγ activation in human keratinocyte HaCaT cells
    Chene, Gerald
    Dubourdeau, Marc
    Balard, Patricia
    Escoubet-Lozach, Laure
    Orfila, Claudine
    Berry, Antoine
    Bernad, Jose
    Aries, Marie-Francoise
    Charveron, Marie
    Pipy, Bernard
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2007, 1771 (05): : 576 - 589
  • [29] Resistance of prostate cancer cell lines to COX-2 inhibitor treatment
    Wagner, M
    Loos, J
    Weksler, N
    Gantner, M
    Corless, CL
    Barry, JM
    Beer, TM
    Garzotto, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (03) : 800 - 807
  • [30] The effect of combined treatment with COX-2 inhibitor and EGFR inhibitor in lung cancer cell lines
    Kim, H. R.
    Kim, N. R.
    Jeong, E. H.
    Lee, T. G.
    Kim, S. Y.
    Kim, C. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S612 - S612
12345